| Literature DB >> 25444993 |
Ryan J Atkins1, Wayne Ng2, Stanley S Stylli2, Christopher M Hovens3, Andrew H Kaye2.
Abstract
Glioblastoma multiforme (GBM) is a malignant and incurable glial brain tumour. The current best treatment for GBM includes maximal safe surgical resection followed by concomitant radiotherapy and adjuvant temozolomide. Despite this, median survival is still only 14-16 months. Mechanisms that lead to chemo- and radio-resistance underpin treatment failure. Insights into the DNA repair mechanisms that permit resistance to chemoradiotherapy in GBM may help improve patient responses to currently available therapies.Entities:
Keywords: Base excision repair; Glioma resistance; MGMT; PARP; Temozolomide chemotherapy
Mesh:
Substances:
Year: 2014 PMID: 25444993 DOI: 10.1016/j.jocn.2014.09.003
Source DB: PubMed Journal: J Clin Neurosci ISSN: 0967-5868 Impact factor: 1.961